Polymyxin Ile-B1 Sulfate
* Please be kindly noted products are not for therapeutic use. We do not sell to patients.

Category | Antibiotics |
Catalog number | BBF-04328 |
CAS | |
Molecular Weight | 1203.47 (free base) |
Molecular Formula | C56H98N16O13.xH2O4S |
Purity | ≥90.0% |
Online Inquiry
Capabilities & Facilities
Fermentation Lab
4 R&D and scale-up labs
2 Preparative purification labs
Fermentation Plant
Semi pilot, pilot and industrial plant 4 Manufacturing sites 7 Production lines at pilot scale 100+ Reactors of 30-4000 L; 170+ reactors of 20 KL-30 KL; 24+ reactors of >100 KL 2 Hydrogenation reactors (200 L, 4Mpa and 1000L, 4Mpa)
Product Description
It is produced by the strain of Pseudomonas Sp. It is one of the individual polypeptide components in polymyxin B sulfate. Polymyxin B targets and alters permeability lipopolysaccharide (LPS) of gram-negative bacteria leading to lysing of the cell.
- Specification
- Properties
- Price Product List
Related CAS | 811435-10-6 (free base) |
Synonyms | Polymyxin B1-I sulfate; Polymyxin II Sulfate; Polymyxin B1 Isoleucine sulfate |
Storage | Store at -20°C |
IUPAC Name | N-[(2S)-4-amino-1-[[(2S,3R)-1-[[(2S)-4-amino-1-oxo-1-[[(3S,6S,9S,12S,15R,18S,21S)-6,9,18-tris(2-aminoethyl)-15-benzyl-12-[(2S)-butan-2-yl]-3-[(1R)-1-hydroxyethyl]-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]amino]butan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-1-oxobutan-2-yl]-6-methyloctanamide;sulfate |
Source | Pseudomonas Sp. |
Appearance | White Powder |
Antibiotic Activity Spectrum | Gram-negative bacteria |
Solubility | Slightly soluble in Water |
BBF-04736 | 3-Indolepropionic acid | Inquiry |
BBF-01738 | Coronatine | Inquiry |
BBF-05877 | Coenzyme Q10 | Inquiry |
BBF-04624 | Sulbactam Sodium | Inquiry |
BBF-03755 | Actinomycin D | Inquiry |
BBF-03211 | AT-265 | Inquiry |
Bio Calculators
Concentration (start) x Volume (start) = Concentration (final) x Volume (final)
It is commonly abbreviated as: C1V1 = C2V2
